Differences in Readmission Rates for Two Total Knee Arthroplasty Prostheses
J Knee SurgDOI: 10.1055/s-0034-1376331The readmission rates of cruciate-retaining (CR) and a posterior-stabilizing (PS) total knee arthroplasty (TKA) have not been extensively evaluated. We aimed to determine the following: (1) What are the readmission rates of TKA performed with the use of CR and PS prostheses at 30, 60, and 90 days following discharge? (2) Were the causes of the unplanned readmission surgically or medically related? (3) What were the medical comorbidities associated with readmission? A prospectively collected database of 845 TKAs (441 CR and 404 PS TKAs) at 22 institutions (24 surgeons) was reviewed. Outcomes evaluated included the incidence of readmission at 30, 60, and 90 days after discharge, medical/surgical cause, and medical comorbidities. There were no significant differences in readmission rates between the two cohorts at the different time points. There was a readmission rate of 2% at 30 days and 3.2% at 60 days for the CR group, and 2.2% at 30 days and 4.0% at 60 days for the PS group after discharge. Medical causes accounted for a majority of the readmissions in both the CR and PS cohort. Readmitted patients had a higher incidence of increased body mass index, cardiovascular disorders, diabetes, and musculoskeletal disorders. The readmission rates for both prostheses in the setting of primary TKA are encouraging because these rates are lower than previously reported outcomes. The authors believe that the positive midterm clinical performance of t...
CONCLUSION: In hypertensive and diabetic patients, higher OPG values were associated with impaired LA function assessed by 2D-STE. In this high-risk patient group, serum OPG can be used as a risk predictor for LA mechanical dysfunction. PMID: 32462219 [PubMed - as supplied by publisher]
Publication date: Available online 29 May 2020Source: Biochimica et Biophysica Acta (BBA) - Proteins and ProteomicsAuthor(s): Khushdeep Bandesh, Dwaipayan Bharadwaj
Publication date: Available online 29 May 2020Source: Advances in PediatricsAuthor(s): Christopher Ferber, Catherine S. Mao, Jennifer K. Yee
One in 10 coronavirus patients with diabetes died within the first seven days of hospitalization, and one in five needed a ventilator to breathe, according to a new study by French researchers.
Authors: Kuwabara-Ohmura Y, Iizuka K, Liu Y, Takao K, Nonomura K, Kato T, Mizuno M, Hosomichi K, Tajima A, Miyazaki T, Horikawa Y, Yabe D Abstract Pancreatic tail hypoplasia is a common manifestation of maturity onset diabetes of the young (MODY) 5 that can cause reno-genito-urinary malformations such as renal cysts and bicornuate uterus. A 69-year-old female was admitted to our hospital for consultation on her relatively high HbA1c value. At age 20, she was diagnosed with uterus bicornis. At age 68, she was diagnosed with pancreas tail hypoplasia, renal cysts and non-functioning pancreatic neuroendocrine tumor (NE...
Publication date: Available online 28 May 2020Source: Diabetes &Metabolic Syndrome: Clinical Research &ReviewsAuthor(s): Dukhabandhu Naik, Felix K. Jebasingh, Nihal Thomas, Sreekanth Raveendran, Samuel C. Raj Pallapati, JohnJude Prakash, S. Gowri, Binu Prathap Thomas
Publication date: Available online 29 May 2020Source: PhytomedicineAuthor(s): Pranav Kumar Prabhakar, Karmveer Singh, Dhiraj Kabra, Jeena Gupta
Omnipod DASH Insulin Management System (mmol/L configuration), Catalog Number PT000011 M/D: INT1D001MM - Product Usage: is intended for subcutaneous delivery of insulin at set and variable rates for the management of diabetes mellitus in persons requiring insulin.
The recent spotlight on obesity and its link to increased COVID-19 mortality risk may be highlighting an issue within medicine itself, before the virus ever appeared, says Dr Yoni Freedhoff.Medscape Diabetes &Endocrinology
U.S. health regulators are telling five drugmakers to recall their versions of metformin, a widely used diabetes medication.